Process optimization in enhancing end-stage iPSC-derived immune-effector cell expansion

Authors

Chen-Yuan Kao, Century Therapeutics, USAFollow
Kyle Smith, Century Therapeutics
Jason A. Mills, Century Therapeutics
Bruno Marques, Century Therapeutics

Conference Dates

February 4 - 8, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Chen-Yuan Kao, Kyle Smith, Jason A. Mills, and Bruno Marques, "Process optimization in enhancing end-stage iPSC-derived immune-effector cell expansion" in "Advancing Manufacture of Cell and Gene Therapies VIII", Fernanda Masri, Cytomos, United Kingdom; Carolyn Yeago, CY Solutions LLC, USA; Gargi Maheshwari, BMS, USA; John Moscariello, BMS, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/cell_gene_therapies_viii/52